Ming-chuan Zhao

发表

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer

Ningning Cheng, Jiayu Li, Ke Fei, 2015, Oncotarget.

MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

Heyong Wang, Zhongwei Lv, Hui Zhang, 2013, Cellular Physiology and Biochemistry.

Analysis of Predictive Factors for Postoperative Survival for Non Small Cell Lung Carcinoma Patients with Unexpected Mediastinal Lymph Nodes Metastasis

Ming-chuan Zhao, Wenyong Zhou, Shaohua Wang, 2013, Thoracic and Cardiovascular Surgeon.

Ef ﬁ cacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial

Lei Wang, Xueqin Chen, Wei Li, 2022 .

Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer

Wa Cao, Ningning Cheng, Jiayu Li, 2015, PloS one.

Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.

Gentao Liu, Ming-chuan Zhao, Heyong Wang, 2013, Toxicology.

A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer

Jae Cheol Lee, Jih-Hsiang Lee, F. Siddiqui, 2017, Oncotarget.

Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.

Gentao Liu, G. Zeng, Caicun Zhou, 2015, Lung cancer.

Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer.

S. Ren, Caicun Zhou, Ningning Cheng, 2015, Oncology reports.

Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients

S. Ren, Caicun Zhou, Ningning Cheng, 2014, Translational oncology.

EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism.

F. Hirsch, Jing Zhao, T. Jiang, 2018, Lung cancer.

The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer

F. Hirsch, S. Ren, Caicun Zhou, 2014, Cancer.

miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin β1 and Matrix Metalloproteinase2 (MMP2)

L. Tang, Peng Zhang, Gentao Liu, 2013, PloS one.

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways

Ming-chuan Zhao, Wenyong Zhou, Hong-Tao Zhang, 2012, Molecular Biology Reports.

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways

Ming-chuan Zhao, Wenyong Zhou, Hong-Tao Zhang, 2011, Molecular Biology Reports.

Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition

Ming-chuan Zhao, Wenyong Zhou, Hong-Tao Zhang, 2011, Molecular and Cellular Biochemistry.

Long non-coding RNA UCA 1 induces non-T 790 M acquired resistance to EGFR-TKIs by activating the AKT / mTOR pathway in EGFR-mutant non-small cell lung cancer

F. Hirsch, Xiaoxiang Chen, S. Ren, 2015 .

Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC.

Caicun Zhou, Ningning Cheng, W. Cai, 2017, Oncology letters.

miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2

Ming-chuan Zhao, Leiping Wang, Xichun Hu, 2020, Technology in cancer research & treatment.

MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type

F. Hirsch, S. Ren, Caicun Zhou, 2014, Oncotarget.

Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer

Ting Li, Ming-chuan Zhao, Jian Zhang, 2023, Journal of Translational Medicine.